![Bing Wu](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bing Wu
Directeur/Bestuurslid bij Beijing Shenogen Pharma Group Ltd.
Actieve functies van Bing Wu
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Directeur/Bestuurslid | 01-10-2019 | - |
Loopbaan van Bing Wu
Opleiding van Bing Wu
Shanghai University of Finance & Economics | Graduate Degree |
Statistieken
Internationaal
China | 3 |
Operationeel
Graduate Degree | 1 |
Director/Board Member | 1 |
Sectoraal
Consumer Services | 2 |
Health Technology | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Beijing Shenogen Pharma Group Ltd.
![]() Beijing Shenogen Pharma Group Ltd. Pharmaceuticals: MajorHealth Technology Beijing Shenogen Pharma Group Co. Ltd. engages in the manufacture of icaritin drug products. It focuses on the treatment of multiple malignant tumors such as hepatocellular carcinoma, breast cancer, non-small cell lung cancer, and lymphoma. The company was founded by Kun Meng and Zhao Yi Wang on May 5, 2008 and is headquartered in Beijing, China. | Health Technology |